SOPHiA GENETICS

SOPHiA GENETICS Liabilities

The The Liabilities of SOPHiA GENETICS (SOPH) as of Nov 9, 2026 is 116.31 M USD. In the previous year, The Liabilities was 58.82 M USD — a change of 97.74% (higher).

Liabilities

116.31 MUSD

YoY

97.74%

Last updated:

In 2025, SOPHiA GENETICS's total liabilities amounted to 116.31 M USD, a 97.74% difference from the 58.82 M USD total liabilities in the previous year.

The SOPHiA GENETICS Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Liabilities
Date
Liabilities
Jan 1, 2019
29.40 M USD
Jan 1, 2020
31.61 M USD
Jan 1, 2021
44.77 M USD
Jan 1, 2022
43.71 M USD
Jan 1, 2023
54.71 M USD
Jan 1, 2024
58.82 M USD
Jan 1, 2025
116.31 M USD
The SOPHiA GENETICS Liabilities history
YEARLiabilitiesYoY
116.31 MUSD+97.74%
58.82 MUSD+7.50%
54.71 MUSD+25.18%
43.71 MUSD-2.38%
44.77 MUSD+41.66%
31.61 MUSD+7.49%
29.40 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

SOPHiA GENETICS Stock analysis

What does SOPHiA GENETICS do? Sophia Genetics SA is a Swiss company that was founded in 2011. The idea behind it was to improve genome sequencing and data analysis in order to make faster and more precise medical diagnoses. Sophia Genetics has since become a leading provider of artificial intelligence and data analysis in the medical field. The business model of Sophia Genetics is based on providing doctors and medical facilities with corresponding data analysis tools and platforms. Sophia Genetics' algorithms help to identify genetic anomalies and develop personalized therapies. This personalized medicine aims to improve healthcare. Sophia Genetics is divided into various sectors. The core sectors include oncology, pediatrics, cardiology, and neurology. In these specialized fields, Sophia Genetics' platforms and tools are used to optimize genome sequencing and data analysis, thus enabling faster and more precise diagnoses. The company offers a variety of products that help doctors and medical facilities create successful diagnoses and therapies. Sophia Genetics' flagship product is the Sophia Artificial Intelligence (AI) platform. This platform is used by doctors, clinics, and research institutions to analyze complex data and identify the genetic causes of diseases. The Sophia AI platform provides fast, precise, and secure genome sequencing and data analysis. Sophia Genetics also offers the Sophia DDM system. The DDM system is a cloud-based data exchange system that provides doctors and medical facilities with a secure way to exchange confidential medical data. The system also allows for the collection and analysis of information about diseases and disease progression in the population, in order to enable better healthcare. Another important product of Sophia Genetics is the Sophia Hereditary Cancer Solution. This product helps in the early detection of hereditary cancer. The Sophia Hereditary Cancer Solution provides fast and precise genetic diagnostics to identify family members at increased risk of cancer and take appropriate measures. Another product of Sophia Genetics is Sophia Radiomics. This software uses artificial intelligence and machine learning to detect and characterize diseases based on X-ray and CT scans. By analyzing large amounts of data, the Sophia Radiomics software can assist doctors in making more precise diagnoses and better treatment decisions. Sophia Genetics relies on close collaboration with medical facilities and research institutions worldwide. The company now has customers in over 60 countries and is a partner to more than 1,000 hospitals worldwide. Sophia Genetics' platforms and tools have already helped many people to be diagnosed and treated faster and more accurately. Overall, Sophia Genetics is an innovative company that has revolutionized medical diagnostics. With its advanced platforms and tools, the company provides doctors and medical facilities with an excellent opportunity to develop personalized therapies and enable better healthcare. SOPHiA GENETICS is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing SOPHiA GENETICS's Liabilities

SOPHiA GENETICS's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating SOPHiA GENETICS's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing SOPHiA GENETICS's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

SOPHiA GENETICS's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in SOPHiA GENETICS’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about SOPHiA GENETICS stock

The Liabilities of SOPHiA GENETICS is 116.31 M USD in 2025.

The Liabilities of SOPHiA GENETICS changed from 58.82 M USD to 116.31 M USD, representing a 97.74% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities SOPHiA GENETICS since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's SOPHiA GENETICS historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — SOPHiA GENETICS

All Key Metrics — SOPHiA GENETICS